Cargando…
Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387785/ https://www.ncbi.nlm.nih.gov/pubmed/34459140 http://dx.doi.org/10.1002/ctm2.505 |
| _version_ | 1783742514446991360 |
|---|---|
| author | Haque Chowdhury, Helena Hawlina, Simon Gabrijel, Mateja Trkov Bobnar, Saša Kreft, Marko Lenart, Gordan Cukjati, Marko Kopitar, Andreja Nataša Kejžar, Nataša Ihan, Alojz Ležaič, Luka Grmek, Marko Kmetec, Andrej Jeras, Matjaž Zorec, Robert |
| author_facet | Haque Chowdhury, Helena Hawlina, Simon Gabrijel, Mateja Trkov Bobnar, Saša Kreft, Marko Lenart, Gordan Cukjati, Marko Kopitar, Andreja Nataša Kejžar, Nataša Ihan, Alojz Ležaič, Luka Grmek, Marko Kmetec, Andrej Jeras, Matjaž Zorec, Robert |
| author_sort | Haque Chowdhury, Helena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8387785 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83877852021-08-31 Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells Haque Chowdhury, Helena Hawlina, Simon Gabrijel, Mateja Trkov Bobnar, Saša Kreft, Marko Lenart, Gordan Cukjati, Marko Kopitar, Andreja Nataša Kejžar, Nataša Ihan, Alojz Ležaič, Luka Grmek, Marko Kmetec, Andrej Jeras, Matjaž Zorec, Robert Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2021-08-26 /pmc/articles/PMC8387785/ /pubmed/34459140 http://dx.doi.org/10.1002/ctm2.505 Text en © 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Haque Chowdhury, Helena Hawlina, Simon Gabrijel, Mateja Trkov Bobnar, Saša Kreft, Marko Lenart, Gordan Cukjati, Marko Kopitar, Andreja Nataša Kejžar, Nataša Ihan, Alojz Ležaič, Luka Grmek, Marko Kmetec, Andrej Jeras, Matjaž Zorec, Robert Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells |
| title | Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells |
| title_full | Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells |
| title_fullStr | Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells |
| title_full_unstemmed | Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells |
| title_short | Survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood CD56(bright)CD16(−) natural killer cells |
| title_sort | survival of castration‐resistant prostate cancer patients treated with dendritic–tumor cell hybridomas is negatively correlated with changes in peripheral blood cd56(bright)cd16(−) natural killer cells |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387785/ https://www.ncbi.nlm.nih.gov/pubmed/34459140 http://dx.doi.org/10.1002/ctm2.505 |
| work_keys_str_mv | AT haquechowdhuryhelena survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT hawlinasimon survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT gabrijelmateja survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT trkovbobnarsasa survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT kreftmarko survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT lenartgordan survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT cukjatimarko survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT kopitarandrejanatasa survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT kejzarnatasa survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT ihanalojz survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT lezaicluka survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT grmekmarko survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT kmetecandrej survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT jerasmatjaz survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells AT zorecrobert survivalofcastrationresistantprostatecancerpatientstreatedwithdendritictumorcellhybridomasisnegativelycorrelatedwithchangesinperipheralbloodcd56brightcd16naturalkillercells |